We describe an efficient in vitro assay to test growth hormone effects on mRNA levels and fatty acid synthase (FAS, EC. 2.3.1.85) activity. Swine adipose tissue explants were long-term cultured in medium containing growth hormone and FAS mRNA levels and enzyme activity were measured. We quantified FAS transcripts by competitive reverse transcriptase PCR (RT-PCR) using total RNA from cultured adipose tissue explants and RT-PCR standard-curves were constructed using a cloned 307 bp segment of native FAS cDNA and a shorter fragment from which a 64 bp (competitor, 243 bp) internal sequence had been deleted. A known amount of competitor was added to each PCR as an internal control and m-actin transcripts were also measured to correct for differences in total RNA extraction and reverse transcription efficiency. In cultures with added growth hormone FAS mRNA levels decreased 70% (p < 0.01) and FAS enzyme activity decreased 22% (p < 0.05). These in vitro growth hormone effects were consistent with those observed in vivo, showing that in vitro adipose tissue culture combined with RT-PCR is a useful and accurate tool for studying growth hormone modulation of adipose tissue metabolism. This technique allowed the diagnosis of lower levels of FAS mRNA in the presence of growth hormone and these low levels were associated with decreased FAS activity in the adipose tissue explants.
Introduction
The mechanisms involved in the control of metabolism by growth hormone have been intensively studied due to the magnitude of its effects. According to Bauman (1999) , metabolic alterations caused by treatment with growth hormone involve long-term responses involving coordinated changes in the metabolism of many tissues. These changes allow the use of nutrients by certain tissues during specific phases of animal development or different physiological states. For instance, the partitioning of nutrients may allow a larger flow of nutrients to the mammary gland for milk synthesis during lactation. These long-term effects include a reduced response to insulin as measured by whole body glucose uptake in vivo as well as a reduced response to insulin stimulation of lipogenesis in vivo and in vitro (Bauman and Vernon, 1993) . In addition, depending on the energy balance, these metabolic changes may include an increase in lipolysis and a decrease in adipose tissue response to the antilipolytic effects of adenosine (Lanna et al., 1995; Lanna and Bauman, 1999) .
In growing swine 80% of fatty acid synthesis occurs de novo using glucose as substrate because only a low proportion of the calories in their normal feed is present as pre-formed fatty acids and about 40% of body glucose usage is destined for fat deposition in adipose tissue (O'Hea and Leville, 1969; Bauman, 1976; Etherton et al., 1995) .
Administration of porcine recombinant growth hormone (pGH) to growing pigs for 30-77 days at the maximally effective doses (>100 mg kg -1 of body weight) increased average daily gain by approximately 10 to 20%, improved productive efficiency 13 to 33%, decreased lipid accretion rates by 70 to 90% and stimulated protein deposition by around 70% (Etherton et al., 1995; Etherton and Bauman, 1998; Etherton, 2004) . Treatment with pGH also enhanced protein deposition in well-nourished growing pigs (Vann et al., 2000) and increased lysine requirements, which is commensurate with increased protein deposition in boars (King et al., 2000) . Sows treated with growth hor-mone at some time during, or even late in, gestation showed an increase in progeny size at birth (Rehfeldt et al., 2004) . The net benefits of pGH administration are the result of re-partition of nutrients from adipose tissue to muscle deposition, and include lower production costs, better product quality and less excretion of nitrogen into the environment. Perhaps the most important effect is increased feed efficiency because this reduces pressure on world feed supplies and the environment (Sillence, 2004) .
Emphasis has been given to the study of growth hormone effects on adipocytes, an important target for this hormone in growing and lactating animals. The main mechanism seems to involve changes in tissue responses to homeostatic signals (Bauman and Vernon, 1993) and in the total activity of rate limiting enzymes, including those controlling lipogenesis and lipolysis (Etherton and Bauman, 1998) . Among adipocyte enzymes, fatty acid synthase (FAS, EC. 2.3.1.85) and acetyl-coenzyme A carboxylase (ACC, EC. 6.4.1.2) seem to be particularly important since their activities are parallel to changes in rates of fatty acids synthesis (Sinnet-Smith et al., 1979) . Therefore, the maximum capacity of adipose tissue to synthesize fatty acids de novo is related to the total amount and specific activity of lipogenic enzymes which in turn is dependent on the levels of mRNA that codify these enzymes (Clarke, 1993) . Growth hormone attenuates the stimulatory effect of insulin on FAS gene transcription and mRNA concentration by increasing mRNA degradation in 3T3-F442A adipocytes (Yin et al., 1998; Yin et al 2001a) and is also known to decrease FAS activity and mRNA concentration in isolated porcine adipocytes (Louveau and Gondret, 2004) . However the mechanism(s) by which growth hormone interferes with the action of insulin on FAS gene transcription has not yet been elucidated (Louveau and Gondret, 2004) .
A clear understanding of the molecular mechanisms by which growth hormone regulates lipogenic enzymes in swine adipose tissue requires the development of in vitro methodologies to reduce the costs and labor required to test a large number of samples and treatments. Here we show that the use of long-term cultures of adipose tissue explants in association with the competitive reverse transcriptase polymerase chain reaction (RT-PCR) to quantify FAS mRNA provides a valuable system to analyze the effects of growth hormone in small samples of adipose tissue.
Material and Methods

Swine adipose tissue cultures
Seven Landrace x Large White castrated male pigs with an average weight 78 kg were humanly slaughtered and used as a source of adipose tissue. The pigs had been fed a 78% corn and 19% soybean meal diet which had a 3.3% ether extract (percentages on a dry matter basis). Around 7% of metabolizable energy was coming from lipids and animals had free access to feed and water until slaughter. The pigs had been bred at the Department of Animal Science, Escola Superior de Agricultura "Luiz de Queiroz", University of São Paulo (ESALQ-USP), Piracicaba, SP, Brazil.
About 20 g of subcutaneous adipose tissue were removed postmortem from the upper leg (ham) of each pig and immediately placed in transport buffer (25 mM HEPES, 0.15 M NaCl, 37°C, pH 7.4). In the laboratory, 30 mg sections (explants) of the intermediate layer of the subcutaneous adipose tissue were aseptically removed and placed into multi-well plates containing Medium 199 with Earle's salts, l-glutamine, 25 mM HEPES and 25 mM bicarbonate, pH 7.4, (Sigma Chemical, St Louis, MO) supplemented with antibiotics (Lanna et al., 1995) . A total of 3 explants per triplicate were used for each hormonal treatment for each pig. Control cultures were supplemented with 0.1 mg mL -1 of insulin and 10 nM of dexamethasone, with experimental growth hormone cultures receiving a further addition of 0.1 mg mL -1 of pGH (Reporcin ® , Southern Cross Biotech, Australia). The cultures were incubated in an atmosphere containing 95% air and 5% CO 2 (v/v) at 37°C for 48 h, after which the explants (~30 mg) from each pig and treatment were collected, grouped into samples and immediately assayed for FAS activity or subjected to total RNA extraction.
Cloning of native and competitor FAS cDNAs
The plasmid pBFAS5 containing a 1.5 kb fragment of cDNA corresponding to the thioesterase domain of the swine FAS gene (Mildner and Clarke, 1991) was kindly donated by Mildner and Clarke (University of Texas, Austin, USA). The cDNA was partially sequenced using the BigDye Terminator Kit (Applied Biosystems, Foster City, CA) on an ABI PRISM 377 automated DNA sequencer. Based on this sequence, the following oligonucleotide primers (Operon Technologies. Inc, Huntsville, AL) were designed: sense (5' CCTACTACATCGAGTGCATC 3') and antisense (5' GGTATCAGCGCCTCCAGCAC 3'). These primers were used for amplification of 307 bp of the cDNA of the FAS gene which we named the native cDNA fragment. A third primer (5' GGTATCAGCGCCTCCAG CACGCCTCGCAGCCGGGGGTCA 3') was designed to delete an internal stretch of the PCR product of the FAS cDNA to produce a 243 bp fragment denominated by us as the competitor fragment. The PCR assay to generate deleted fragments has been described by Kotake et al. (1996) . The primers for b-actin amplification were designed based on the sequence published by McNeel and Mersmann (1999) . The b-actin primers were: sense 5' CTAGGCAC CAGGGCGTCATC 3'; antisense 5' CTTAGGGTTCAG GGGGGCCT 3'; and antisense deletion 5' CTTAGGG TTCAGGGGGGCCTTAGAAGGTGTGGTGCCAGA 3'. The fragment corresponding to the b-actin native cDNA fragment was 227 bp and the b-actin competitor cDNA fragment was 180 bp. The PCR products corresponding to native and competitor cDNAs were cloned in pGEM4Z/ Escherichia coli JM109 using the SureClone Ligation Kit (Pharmacia Biotech, Carlsbad, CA). All clones were sequenced using the BigDye Terminator Kit and the ABI PRISM 377 automated DNA sequencer before performing the quantitative RT-PCR assays.
Standard curves for FAS and b-Actin
Standard curves for the quantification of FAS transcripts were obtained by co-amplifying 1:1 serial dilutions of the native cDNA (25.6 to 0.1 x 10 -3 fmol) with a constant amount of the cDNA competitor (10 -3 fmol), in 100 ng of total RNA. After PCR, amplified products were loaded onto 4.25% denaturing acrylamide gels and submitted to electrophoresis in an Automated Laser Fluorescent DNA Sequencer (A.L.F.
TM
, Pharmacia LKB Biotechnology, Carlsbad, CA). Following electrophoresis, peak areas of native and competitor products were integrated using the Fragment Manager software (Pharmacia LKB Biotechnology, Carlsbad, CA). The logarithmic proportion between the native and competitor areas (log(N/C)) was plotted on the Y axis while the logarithm of the amount of native cDNA added to the reaction (log Ni) was plotted on the X axis of the standard curve. An equation obtained by linear regression of the standard curves was used to determine the initial number of mRNA molecules for FAS in the samples of adipose tissue explants. The standard b-actin curve was obtained in a similar way by modifying the concentration of the native and competitor cDNAs to concentrations of 10 -4 fmol. A detailed description of the methodology used in our competitive RT-PCR assays has been described by Alvares et al. (2003) .
Quantitative RT-PCR
After 48 h in culture, 3 to 4 explants (~30 mg each) from each pig and treatment were collected, combined to approximately 100 mg, pulverized in liquid nitrogen and submitted to total RNA extraction with Trizol reagent (Life Technologies, Rockville, MD). Samples were dissolved in RNAse-free water and quantified using the mean of duplicate spectrophotometric readings at 260 nm (A260). Purity of total RNA was determined by the A260:A280 ratio. The integrity of each RNA sample was checked by electrophoresis on 1% agarose gels. cDNA samples were prepared from 1 mg of total RNA, using oligo (dT) primer. The synthesis of cDNAs were performed with the Superscript II Preamplification System kit (Life Technologies. Rockville, MD) according to manufacturers protocol.
The competitive PCRs, containing 2 mL cDNA and a known amount of competitor cDNA, were prepared in a final volume of 25 mL. In addition to templates, the reactions contained 1 X PCR buffer (10 mM tris-HCl pH 8.3, 50 mM KCl, 0.01% Triton X-100), 1.5 mM (FAS) or 1.0 mM MgCl 2 (m-actin), 200 mM dNTPs, 5 pM of the sense and antisense primers and 1.25 U of Taq DNA polymerase (Life Technologies, Rockville, MD). Sense primers were 5'-labeled with fluorescein for subsequent detection of PCR products in the A.L.F. automated DNA sequencer. The PCR parameters consisted of an initial denaturation at 95°C for 3 min, followed by annealing at 57°C for 1 min and extension at 74°C for 1 min, except for the last cycle when extension took 10 min. The same conditions were used in the PCR programs for amplification of the FAS (24 cycles) and the m-actin fragments (34 cycles).
Enzymatic activity assay
The FAS assay was performed according to ingle et al. (1973) , with some modifications. Samples of cultured explants for each treatment were homogenized in a polytron in 3 mL of 0.15 M KCl, 50 mmol tris-buffer, 1 mmol glutathione and 1 mmol EDTA buffer at 4°C and pH 7.4. The FAS activity was calculated spectrophotometrically at 340 nm from the rate of transformation of NADPH to NADP in incubations containing substrate, cofactors and homogenated adipose tissue. The concentrations of the reagents were: 40 mm of potassium phosphate buffer plus EDTA (pH 6.8), 0.1 mm malonyl-CoA, 0.1 mm acetylCoA, 0.3 mm NADPH and 0.4 mmol of dithiothreitol. Protein concentration in the homogenate was determined by the Biuret method (Gornall et al. 1949 ) using bovine serum albumin as standard and the activities expressed as nmoles min 
Statistical analysis
Paired data was analyzed using the t-test (SAS, 1999) . For mRNA concentration, the FAS values were corrected for the concentration of b-actin mRNA. The same statistical design was used for analysis of FAS enzymatic activity.
Results and Discussion
Growth hormone effects on FAS Activity
We found that FAS activity decreased (p < 0.05) by 22% as a result of adipose tissue explants being cultured for 48 h in the presence of pGH (Table 1) . A similar decrease in the enzymatic activity has been observed in cultures of adipose tissue explants (Lanna et al., 1994) and also in isolated adipocytes cultured for 48 h (Louveau and Gondret, 2004) . However, the magnitude of the reduction in activity was smaller than that observed with swine adipose tissue explants biopsied after 1 to 4 weeks of in vivo treatment with pGH, which showed a 40 to 80% reduction in FAS activity (Harris et al., 1993; Donkin et al., 1996a; Lee et al., 2000) . Differences from studies in vitro and in vivo can be reconciled because of the long FAS protein half-life of around 48 h (Dice and Goldberg, 1975) . The in vivo studies al- Effect of GH on fatty acid synthase gene expression lowed sufficient time for bST to reduce not only mRNA expression, but to reduce FAS protein concentrations.
Native and competitive FAS cDNA standard curves The standard curve obtained for FAS mRNA is shown in Figure 1B . As the intensity of native FAS cDNA products decreased, there was, as expected, a gradual increase in the intensity of competitor products ( Figure 1A ).
Bands showing approximately the same signal intensity for the native (3447.1 pixels) and competitor (3459.8 pixels) products were observed at the 3.2 fmols dilution, indicating that the competitor had higher amplification efficiency than the native cDNA. The higher efficiency of the competitor cDNA amplification is reflected in the negative value for the intercept (Alvares et al., 2003) .
Effect of growth hormone on FAS gene expression
The amount of FAS mRNA in the adipose tissue cultures after 48 h treatment with pGH was calculated both with and without a correction for the b-actin housekeeping gene, the uncorrected means showing a non-significant 57% decrease while the b-actin corrected values showed a significant decrease of 70% (p < 0.05; Table 1 ). A decrease in FAS mRNA has also been observed when animals were treated in vivo with pGH (Harris et al., 1993; Mildner and Clarke, 1991; Donkin et al., 1996a; 1996b; Yin et al., 1998) , suggesting that growth hormone causes decreased FAS gene expression. Moreover, Yin and co-workers (1998) observed a reduction in the stability of FAS mRNA, whose half-life of 35 h decreased to 11 h when mRNA degradation increased.
Such changes in gene expression support the observed decrease in the capacity of adipose tissue to synthesize lipids as measured by the incorporation of labeled glucose in live pigs (Dunshea et al., 1992b; Harris et al., 1993; Lanna et al., 1994; Donkin et al., 1996a; Yin et al., 1998) and labeled acetate in ruminants (Ingle et al., 1973; Vernon and Finley, 1988; Borland et al., 1994; Lanna et al., 1995; Lanna and Bauman, 1999) . Studies with long-term in vivo growth hormone treatment followed by biopsies and evaluation of adipose metabolism in vitro by Harris et al. (1993) demonstrated that pGH dramatically reduces lipogenesis rates. The work by Harris also demonstrated a sharp decrease in the activity of the enzymes responsible for de novo fatty acid synthesis, particularly FAS. This is consistent with the FAS concentration having a decisive role in the maximum capacity of adipose tissue to synthesize fatty acids de novo (Clarke, 1993) . Along with the changes in FAS activity, the amount of acetyl-CoA carboxylase (ACC) is also known to be reduced in both ruminant and non-ruminant animals treated with growth hormone (Vernon and Finley 1988; Magri et al., 1990; Vernon et al., 1991; Harris et al., 1993; Lanna et al., 1995; Lanna and Bauman, 1999) . Vernon & Finley (1988) and Vernon et al. (1991) observed that growth hormone inhibited the increase in lipogenic rates and ACC activity caused by insulin and dexamethasone and that this effect was abolished by actinomycin D. It appears that growth hormone inhibits the synthesis of key proteins in this process, including factors involved in the transduction of the signals controlling lipogenesis. The growth hormone effects observed by Vernon et al. (1991) occurred within 4-8 h, however, due to the long half-lives of FAS and ACC, growth hormone effects during shorter periods should involve components of the activation and signaling pathways of the enzymes, while in the long-term (over 48 h) treatment with growth hormone José et al. 183 would affect the amount of enzymes. Given the half-life of FAS mRNA, a decrease in FAS mRNA should occur earlier than a decrease in the amount of enzyme and total enzymatic activity. Ingle et al. (1973) observed that in sheep given access to feed after a fasting period there was a strong correlation (r = 0.95) between ACC activity and lipogenesis as measured in vitro by the incorporation of labeled acetate into lipids. The synthesis of fatty acids was reduced by 91% after 60 h and 95% after 112 h of feed deprivation although FAS and ACC activities were reduced by only 40% after 96 h of fasting. The slower reductions in lipogenic enzyme activities than in lipid synthesis after feed deprivation seem to be consistent with those observed with growth hormone.
Using the quantitative competitive reverse transcriptase (QC-RT-PCR) described in this study we observed a reduction in the concentration of FAS mRNA in adipose tissue from swine submitted to 48 h fasting, i.e. from 10 for fasted animals (José et al., 1999) . In that experiment after fasting for 48 h pigs were given access to feed for 24 h and displayed FAS mRNA concentrations similar to controls fed ad libitum throughout the period. In these fasting/refeeding studies the QC-RT-PCR technique detected small difference between FAS mRNA levels and demonstrated that QC-RT-PCR may be applied to the evaluation of a variety of diet and hormonal treatments.
Regulation of gene expression of the key enzymes of lipid synthesis is also controlled by several factors including animal age, nutritional state, diet composition, proportion of carbohydrates and fats, profile and degree of saturation of the fatty acids as well as hormonal effects. Girard et al. (1997) designed a series of studies demonstrating the role of FAS in the regulation of fat synthesis in the course of the development of mice fed with diets of different composition. They observed, together with Towle et al. (1997) , that low fat diets with high amounts of simple carbohydrates can induce a group of key enzymes (particularly FAS) involved in lipogenesis in the liver of mammals. This regulatory system seems to be partly effected by the action of intermediate metabolites that activate transcription factors. This activation of transcription factors that lead to changes in the amounts of the mRNA of those key enzymes seems to involve both glucose-6-phosphate and elements of the insulin cascade.
The precise mechanisms involved in the insulin antilipolytic effect are still unclear, but include a reduction in the intracellular concentration of cAMP, stimulation of low Km phosphodiesterase and phosphatases capable of dephosphorylation and inactivation of hormone sensitive lipase. Yin et al. (1998) observed an increase of 2 to 13 fold in FAS mRNA concentration and 3 to 7 fold in rates of lipid synthesis in cells treated with insulin and found that growth hormone reduced the stimulatory effects of insulin on FAS mRNA concentration by 40 to 70% and lipogenesis by 20 to 60%.
In swine, the most important effect of growth hormone in adipose tissue results from changes in lipogenesis, with lipolysis rates being relatively unaffected (Etherton and Bauman, 1998 and Dunshea et al., 1992a) . Dunshea et al. (1992a) administered radioactively labeled glucose and fatty acids to growing pigs treated with pGH and found that in pigs with a positive energy balance decreases in lipid deposition were the result of decreased lipid synthesis without any changes in rates of fatty acid mobilization from body reserves (Dunshea et al., 1992a) .
In our adipose tissue cultures with insulin and dexamethasone, addition of pGH caused a decrease in FAS gene expression, expressed as a 22% reduction in total enzymatic activity (significant at p < 0.05) and a 70% reduction in FAS mRNA (significant at p < 0.01). Under these in vitro conditions the addition of pGH to the culture medium did not affect the concentration of m-actin mRNA (p = 0.74).
In our experiments there was no insulin-free control, and thus it may be argued that pGH only inhibited insulin stimulation of FAS gene transcription. It is indeed possible that the pGH might only act indirectly through modulation of the insulin-signaling cascade. The mechanism by which growth hormone interferes with the action of insulin on FAS gene transcription has not yet been totally elucidated (Louveau and Gondret, 2004) . Magri et al. (1990) observed that a decrease in insulin sensibility caused by growth hormone in swine adipose tissue was neither associated with changes in the number of insulin receptors nor in tyrosine kinases activity. Our laboratory has demonstrated a decrease in PI3 kinase associated with both IRS-1 (insulin receptor substrate) and IRS-3 in adipose tissue (Castro et al., 2004) while others have demonstrated the same for IRS-1 and IRS-2 in muscle (Thirone et al., 1997 (Thirone et al., , 1998 . According to Donkin et al. (1996b) two mechanisms can exist by which pGH can antagonize insulin effects on FAS transcription. One mechanism could involve interference with the signaling cascade reducing the trans-activation factors which interact with key cis elements of the insulin response (IRE) factors which are positive regulators of FAS transcription. The other possible mechanism is a growth hormone response element, or somatotrophic response element (STRE), in the FAS gene that acts as a negative control. Such a response element has indeed been demonstrated in the gene. Yin et al. (2001b) suggested that the somatotrophic response element may be located within the first 112 bp of the FAS promoter. One possible candidate is the sterol regulatory element binding protein (SREBP)-1c, a member of the helix-loop-leucine zipper family of transcription factors, which has been reported to play a pivotal role in mediating the effects of insulin in liver (Foufelle and Ferré, 2002) . Frick et al (2002) observed that when growth hormone was administered to rats for 7 days there was increased expression of FAS and SREBP-1c in the livers of the rats. Insulin and growth hormone had no additive effects on these genes, instead insulin blunted the effect of growth hormone on SREBP-1c mRNA. In contrast to liver, adipose tissue expression of FAS and SREBP-1c mRNA was not influenced by growth hormone. Frick et al. (2002) concluded that the increased hepatic expression of lipogenic enzymes after growth hormone treatment may be explained by increased expression of SREBP-1c and insulin does not mediate the effects of growth hormone but inhibits the stimulatory effect of growth hormone on hepatic SREBP-1c expression and triglyceride secretion rate. The same observation was made by Louveau and Gondret (2004) who treated isolated porcine adipocytes with growth hormone and insulin and found that the regulation of lipogenesis appears not to involve changes in SREBP-1 mRNA levels. Glucose incorporation and FAS activity were increased by insulin in a dose-dependent manner and addition of pGH inhibited insulin-stimulated FAS activity. Such inhibition was strongly paralleled by variations in FAS mRNA, after 2 days of culture. These data are consistent with our results where pGH decreased FAS activity and FAS mRNA concentration after 2 days of culture even though the culture systems and evaluation methods were different to those of Louveau and Gondret (2004) .
Besides the work developed with primary adipose tissue culture, including the system described by us in this paper, studies with cell lineages such as 3T3-F442A have been used for observations of the effects of several treatments affecting lipogenesis including growth hormone (Yin et al., 1998 , Yin et al., 2001a . Data from these studies suggest that cell lineages are an appropriate model for the investigation of the antagonistic effects of growth hormone on insulin. The magnitude of the reductions in the concentration of FAS mRNA observed by Yin et al. in the studies cited above was close to that observed by us.
Despite the consistency of the data from cell lineages and primary cultures of adipocytes, cell lineages differ metabolically from normal cells in several ways, including the fact that they are immortal. Therefore even though cell lineage data agree with other reports cell linage data should still be regarded with caution.
Conclusions
Using competitive reverse transcriptase PCR (RT-PCR) and long-term cultures of adipose tissue explants, the growth hormone effects on gene expression of the lipogenic enzyme FAS can be evaluated in a defined medium. Our results were very similar to those from other in vitro and in vivo work in that we found that chronic treatment with porcine growth hormone (pGH) decreased fatty acid synthase (FAS) gene expression as measured both by mRNA content and total enzymatic activity of swine adipose tissue.
